MedTrace Logo

Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function

NCT02187601 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-12-20

No results posted yet for this study

Summary

The aim of the study is to confirm that the new generation state of the art breath analyzer gives equivalent results to the previous model of the Exalenz breath analyzer.

Conditions

  • Chronic Liver Disease (CLD)
  • Healthy Volunteers

Interventions

DEVICE

MPBA System

MPBA is the new generation Multi Purpose Breath Analyzer

DEVICE

BreathID

BreathID is the name of the original Exalenz breath analyzer system

Sponsors & Collaborators

  • Meridian Bioscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Saleh Daher, MD · Hadassah Medical Organization

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02187601 on ClinicalTrials.gov